Literature DB >> 8119969

Isolation and characterization of thrombin-activated human factor VIII.

J E Curtis1, S L Helgerson, E T Parker, P Lollar.   

Abstract

Recombinant human factor VIII (fVIII) was activated by thrombin at pH 7.4, followed by CM-Sepharose chromatography at pH values ranging from 3.5 to 7.4. Optimal coagulant activity was recovered at pH 5.5 and was associated with the isolation of an A1/A2/A3-C1-C2 heterotrimer. The activity was stable at -80 degrees C, but decayed slowly (t1/2 approximately 1 week) and nonproteolytically at room temperature or 4 degrees C. The coagulant activity of the pH 5.5 fVIIIa preparation assayed in human hemophilia A plasma was only 20% that of porcine factor VIIIa. However, its activity was approximately 75% that of porcine fVIIIa in a plasma-free assay, indicating that human fVIIIa is unstable relative to porcine fVIIIa during the coagulation assay. The first-order rate constant for spontaneous, nonproteolytic loss of activity of human fVIIIa at pH 7.4 was decreased 8-fold by fIXa and phospholipid, indicating that human fVIIIa is stabilized when incorporated into the intrinsic pathway factor X activation complex.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8119969

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.

Authors:  R De Cristofaro; V De Filippis
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

2.  Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.

Authors:  M Monaghan; H Wakabayashi; A E Griffiths; P J Fay
Journal:  J Thromb Haemost       Date:  2016-03-21       Impact factor: 5.824

3.  Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation.

Authors:  Mettine H A Bos; Rodney M Camire
Journal:  J Coagul Disord       Date:  2010-07-01

4.  Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.

Authors:  Frauke Swieringa; Marijke J E Kuijpers; Moniek M E Lamers; Paola E J van der Meijden; Johan W M Heemskerk
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

5.  Inhibition of human factor VIIIa by anti-A2 subunit antibodies.

Authors:  P Lollar; E T Parker; J E Curtis; S L Helgerson; L W Hoyer; M E Scott; D Scandella
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 6.  The molecular basis of factor V and VIII procofactor activation.

Authors:  R M Camire; M H A Bos
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

7.  Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13.

Authors:  Wenjing Cao; Sriram Krishnaswamy; Rodney M Camire; Peter J Lenting; X Long Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-20       Impact factor: 11.205

8.  Biophysical characterization of anticoagulant hemextin AB complex from the venom of snake Hemachatus haemachatus.

Authors:  Yajnavalka Banerjee; Rajamani Lakshminarayanan; Subramanian Vivekanandan; Ganesh Srinivasan Anand; Suresh Valiyaveettil; R Manjunatha Kini
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

9.  Activated protein C has a regulatory role in factor VIII function.

Authors:  Amelia R Wilhelm; Nicole A Parsons; Benjamin J Samelson-Jones; Robert J Davidson; Charles T Esmon; Rodney M Camire; Lindsey A George
Journal:  Blood       Date:  2021-05-06       Impact factor: 22.113

10.  Blood Clotting Factor VIII: From Evolution to Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov; A I Vorobiev
Journal:  Acta Naturae       Date:  2013-04       Impact factor: 1.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.